Related Experiment Video
Updated: Aug 2, 2026

Genetic Manipulation of the Plant Pathogen Ustilago maydis to Study Fungal Biology and Plant Microbe Interactions
Published on: September 30, 2016
Blocking drug efflux mechanisms facilitate genome engineering process in hypercellulolytic fungus, Penicillium
Anmoldeep Randhawa1,2, Nandita Pasari1,3, Tulika Sinha1
1Microbial Engineering Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, 110067, India.
Background:
Penicillium funiculosum NCIM1228 is a non-model filamentous fungus that produces high-quality secretome for lignocellulosic biomass saccharification. Despite having desirable traits to be an industrial workhorse, P. funiculosum has been underestimated due to a lack of reliable genetic engineering tools. Tolerance towards common fungal antibiotics had been one of the major hindrances towards development of reliable transformation tools against the non-model fungi. In this study, we sought to understand the mechanism of drug tolerance of P. funiculosum and the provision to counter it. We then attempted to identify a robust method of transformation for genome engineering of this fungus.
Results:
Penicillium funiculosum showed a high degree of drug tolerance towards hygromycin, zeocin and nourseothricin, thereby hindering their use as selectable markers to obtain recombinant transformants. Transcriptome analysis suggested a high level expression of efflux pumps belonging to ABC and MFS family, especially when complex carbon was used in growth media. Antibiotic selection medium was optimized using a combination of efflux pump inhibitors and suitable carbon source to prevent drug tolerability. Protoplast-mediated and Agrobacterium-mediated transformation were attempted for identifying efficiencies of linear and circular DNA in performing genetic manipulation. After finding Ti-plasmid-based Agrobacterium-mediated transformation more suitable for P. funiculosum, we improvised the system to achieve random and homologous recombination-based gene integration and deletion, respectively. We found single-copy random integration of the T-DNA cassette and could achieve 60% efficiency in homologous recombination-based gene deletions. A faster, plasmid-free, and protoplast-based CRISPR/Cas9 gene-editing system was also developed for P. funiculosum. To show its utility in P. funiculosum, we deleted the gene coding for the most abundant cellulase Cellobiohydrolase I (CBH1) using a pair of sgRNA directed towards both ends of cbh1 open reading frame. Functional analysis of ∆cbh1 strain revealed its essentiality for the cellulolytic trait of P. funiculosum secretome.
Conclusions:
In this study, we addressed drug tolerability of P. funiculosum and developed an optimized toolkit for its genome modification. Hence, we set the foundation for gene function analysis and further genetic improvements of P. funiculosum using both traditional and advanced methods.
Insights
Penicillium funiculosum exhibits high drug tolerance, hindering genetic engineering. This study optimized transformation methods and developed CRISPR/Cas9 tools, enabling gene function analysis and improving this fungus for industrial applications.
Area of Science:
- Mycology and Industrial Biotechnology
- Genetic Engineering of Filamentous Fungi
Background:
- Penicillium funiculosum NCIM1228 is a non-model fungus with industrial potential for lignocellulosic biomass saccharification.
- Limited genetic engineering tools hinder its application due to high tolerance to common antibiotics.
- Understanding and overcoming drug tolerance is crucial for developing reliable transformation methods.
Purpose of the Study:
- To investigate the drug tolerance mechanisms in P. funiculosum.
- To develop and optimize genetic engineering tools for P. funiculosum.
- To establish a foundation for gene function analysis and strain improvement.
Main Methods:
- Transcriptome analysis to identify efflux pump expression.
- Optimization of antibiotic selection medium with efflux pump inhibitors.
- Comparison of protoplast-mediated and Agrobacterium-mediated transformation.
- Development of CRISPR/Cas9 gene editing system for P. funiculosum.
Main Results:
- P. funiculosum shows high tolerance to hygromycin, zeocin, and nourseothricin.
- Efflux pumps (ABC and MFS families) are highly expressed, contributing to drug tolerance.
- Optimized selection medium and Ti-plasmid-based Agrobacterium-mediated transformation were effective.
- Achieved 60% efficiency in homologous recombination-based gene deletions and developed a CRISPR/Cas9 system.
- Deletion of Cellobiohydrolase I (CBH1) gene confirmed its essentiality for cellulolytic activity.
Conclusions:
- Drug tolerability in P. funiculosum was addressed by optimizing selection conditions.
- An efficient toolkit for genome modification, including CRISPR/Cas9, was developed.
- This work enables future genetic studies and improvements of P. funiculosum for industrial use.
Related Concept Videos
Bioreactor Controls-III
Production of Antibiotics

